Vabysmo 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection Images
Generic Name: faricimab
This medication has been identified as Vabysmo 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection. It is supplied by Genentech, Inc.
Vabysmo is used in the treatment of Macular Edema; Macular Edema Following Retinal Vein Occlusion; Diabetic Macular Edema; Macular Degeneration and belongs to the drug class anti-angiogenic ophthalmic agents. Vabysmo 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Vabysmo
- Generic Name
- faricimab
- Strength
- 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0096
See also:
Syfovre
Syfovre (pegcetacoplan) treatment for geographic atrophy (GA) a form of dry age-related macular ...
Eylea
Eylea is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema ...
Izervay
Izervay (avacincaptad pegol) is used for treating geographic atrophy (GA) due to age-related ...
Ozurdex
Ozurdex is an implant injected into the eye to treat swelling that may occur when there is a ...
Lucentis
Lucentis is used to treat the wet form of age-related macular degeneration. Learn about side ...
Pavblu
Pavblu (aflibercept-ayyh) is a biosimilar to Eylea that may be used to treat the following eye ...
Byooviz
Byooviz injection is used to treat types of macular degeneration, macular edema and mCNV. Byooviz ...
Eylea HD
Eylea HD is used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic ...
Maxidex
Maxidex is used for conjunctivitis, conjunctivitis, allergic, cyclitis, iritis, keratitis, macular ...
More about Vabysmo (faricimab ophthalmic)
- Compare alternatives
- Pricing & coupons
- Reviews (34)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.